EDIT Cash from Financing Activities - Cash Flow Statement - Editas Medicine, Inc. - IntrinsicAlpha

Editas Medicine, Inc. EDIT

Healthcare - Biotechnology - NASDAQ - US

$ 1.22

-1.61 %

$ 101 M

Market Cap

-0.48

P/E

EDIT - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities EDIT - Editas Medicine, Inc.

118 M

LAST VALUE

-35.31%

2 YEAR CAGR

6.31%

5 YEAR CAGR

29.38%

10 YEAR CAGR